HEADER TRANSFERASE/TRANSFERASE INHIBITOR 05-MAY-10 3MW1 TITLE P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAP KINASE 14, MAPK 14, MITOGEN-ACTIVATED PROTEIN KINASE P38 COMPND 5 ALPHA, MAP KINASE P38 ALPHA, CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY COMPND 6 DRUG-BINDING PROTEIN, CSAID-BINDING PROTEIN, CSBP, MAX-INTERACTING COMPND 7 PROTEIN 2, MAP KINASE MXI2, SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK14; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH10B-R; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SAREUM PROPRIETARY PT7-NH2 VECTOR KEYWDS P38 MAP KINASE, TRANSFERASE, INHIBITOR COMPLEX, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR V.SEGARRA,F.CATURLA,W.LUMERAS,R.ROCA,M.FISHER,M.LAMERS REVDAT 3 01-NOV-23 3MW1 1 REMARK REVDAT 2 07-DEC-11 3MW1 1 JRNL VERSN REVDAT 1 27-APR-11 3MW1 0 JRNL AUTH W.LUMERAS,L.VIDAL,B.VIDAL,C.BALAGUE,A.ORELLANA,M.MALDONADO, JRNL AUTH 2 M.DOMINGUEZ,V.SEGARRA,F.CATURLA JRNL TITL 1,7-NAPHTHYRIDINE 1-OXIDES AS NOVEL POTENT AND SELECTIVE JRNL TITL 2 INHIBITORS OF P38 MITOGEN ACTIVATED PROTEIN KINASE JRNL REF J.MED.CHEM. V. 54 7899 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21999461 JRNL DOI 10.1021/JM200975U REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH W.LUMERAS,J.-F.CATURLA,L.VIDAL,C.ESTEVE,C.BALAGUE, REMARK 1 AUTH 2 A.ORELLANA,M.DOMINGUEZ,R.ROCA,J.M.HUERTA,N.GODESSART,B.VIDAL REMARK 1 TITL DESIGN, SYNTHESIS, AND STRUCTURE-ACTIVITY RELATIONSHIPS OF REMARK 1 TITL 2 AMINOPYRIDINE N-OXIDES, A NOVEL SCAFFOLD FOR THE POTENT AND REMARK 1 TITL 3 SELECTIVE INHIBITION OF P38 MITOGEN ACTIVATED PROTEIN KINASE REMARK 1 REF J.MED.CHEM. V. 52 5531 2009 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 19678708 REMARK 1 DOI 10.1021/JM9008604 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 3 NUMBER OF REFLECTIONS : 11267 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.259 REMARK 3 R VALUE (WORKING SET) : 0.255 REMARK 3 FREE R VALUE : 0.339 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 547 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 817 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.41 REMARK 3 BIN R VALUE (WORKING SET) : 0.3490 REMARK 3 BIN FREE R VALUE SET COUNT : 52 REMARK 3 BIN FREE R VALUE : 0.4960 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2725 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.41000 REMARK 3 B22 (A**2) : 0.27000 REMARK 3 B33 (A**2) : 0.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.510 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.379 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.847 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.917 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.870 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2824 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1871 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3843 ; 1.199 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4570 ; 0.855 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 339 ; 6.228 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 129 ;39.153 ;24.341 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 472 ;18.706 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;21.485 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 432 ; 0.062 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3103 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 560 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1710 ; 0.455 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 679 ; 0.053 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2766 ; 0.857 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1114 ; 0.927 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1077 ; 1.623 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3MW1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1000059064. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11267 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.92 REMARK 200 R MERGE FOR SHELL (I) : 0.37700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 3HRB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG 3350, 0.2M NACL, 0.1 M BIS REMARK 280 -TRIS PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.63000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.40500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.61500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.40500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.63000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.61500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 2 REMARK 465 GLN A 3 REMARK 465 SER A 32 REMARK 465 GLY A 33 REMARK 465 ALA A 34 REMARK 465 TYR A 35 REMARK 465 GLY A 36 REMARK 465 ARG A 173 REMARK 465 HIS A 174 REMARK 465 LEU A 353 REMARK 465 ASP A 354 REMARK 465 GLN A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 MET A 358 REMARK 465 GLU A 359 REMARK 465 SER A 360 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 4 CG CD OE1 OE2 REMARK 470 LYS A 15 CG CD CE NZ REMARK 470 LEU A 55 CB CG CD1 CD2 REMARK 470 ARG A 57 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 63 CG1 CG2 CD1 REMARK 470 ARG A 67 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 118 CG CD CE NZ REMARK 470 ARG A 149 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 201 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 5 115.89 71.23 REMARK 500 ASN A 14 71.72 52.10 REMARK 500 LYS A 15 -23.12 81.52 REMARK 500 GLU A 22 -39.33 -29.87 REMARK 500 VAL A 30 -54.20 -156.46 REMARK 500 HIS A 80 142.57 -170.09 REMARK 500 ASN A 100 14.54 -160.15 REMARK 500 ASN A 115 27.66 -73.21 REMARK 500 ILE A 116 -48.30 -152.48 REMARK 500 VAL A 117 -99.56 -73.29 REMARK 500 LYS A 118 97.62 60.18 REMARK 500 CYS A 119 66.39 39.35 REMARK 500 LYS A 121 97.56 -62.04 REMARK 500 ASP A 145 65.82 25.12 REMARK 500 ARG A 149 -39.54 74.95 REMARK 500 ASP A 168 77.33 44.25 REMARK 500 GLU A 192 -18.66 -49.14 REMARK 500 ASN A 196 62.68 31.14 REMARK 500 ASN A 201 -172.58 -61.88 REMARK 500 PHE A 223 67.68 -117.49 REMARK 500 SER A 251 46.00 -95.28 REMARK 500 GLU A 253 -37.60 -40.00 REMARK 500 PHE A 274 64.70 -103.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MIH A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HRB RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ANOTHER INHIBITOR DBREF 3MW1 A 2 360 UNP Q16539 MK14_HUMAN 2 360 SEQRES 1 A 359 SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU LEU ASN SEQRES 2 A 359 LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN ASN LEU SEQRES 3 A 359 SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL CYS ALA SEQRES 4 A 359 ALA PHE ASP THR LYS THR GLY LEU ARG VAL ALA VAL LYS SEQRES 5 A 359 LYS LEU SER ARG PRO PHE GLN SER ILE ILE HIS ALA LYS SEQRES 6 A 359 ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS MET LYS SEQRES 7 A 359 HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE THR PRO SEQRES 8 A 359 ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR LEU VAL SEQRES 9 A 359 THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE VAL LYS SEQRES 10 A 359 CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE LEU ILE SEQRES 11 A 359 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 12 A 359 ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN LEU ALA SEQRES 13 A 359 VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU ASP PHE GLY SEQRES 14 A 359 LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY TYR VAL SEQRES 15 A 359 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 16 A 359 TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SER VAL SEQRES 17 A 359 GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG THR LEU SEQRES 18 A 359 PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS LEU ILE SEQRES 19 A 359 LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU LEU LYS SEQRES 20 A 359 LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE GLN SER SEQRES 21 A 359 LEU THR GLN MET PRO LYS MET ASN PHE ALA ASN VAL PHE SEQRES 22 A 359 ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU GLU LYS SEQRES 23 A 359 MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR ALA ALA SEQRES 24 A 359 GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR HIS ASP SEQRES 25 A 359 PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP GLN SER SEQRES 26 A 359 PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP LYS SER SEQRES 27 A 359 LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO PRO PRO SEQRES 28 A 359 LEU ASP GLN GLU GLU MET GLU SER HET MIH A 1 33 HETNAM MIH 8-(2,6-DICHLOROPHENYL)-4-(2,4-DIFLUOROPHENYL)-2- HETNAM 2 MIH PIPERIDIN-4-YL-1,7-NAPHTHYRIDINE 7-OXIDE FORMUL 2 MIH C25 H19 CL2 F2 N3 O FORMUL 3 HOH *36(H2 O) HELIX 1 1 SER A 61 MET A 78 1 18 HELIX 2 2 THR A 123 SER A 143 1 21 HELIX 3 3 LYS A 152 SER A 154 5 3 HELIX 4 4 ASP A 176 THR A 180 5 5 HELIX 5 5 ALA A 190 LEU A 195 1 6 HELIX 6 6 THR A 203 GLY A 219 1 17 HELIX 7 7 ASP A 227 GLY A 240 1 14 HELIX 8 8 GLY A 243 ILE A 250 1 8 HELIX 9 9 SER A 252 LEU A 262 1 11 HELIX 10 10 ASN A 269 PHE A 274 1 6 HELIX 11 11 ASN A 278 LEU A 289 1 12 HELIX 12 12 ASP A 292 ARG A 296 5 5 HELIX 13 13 THR A 298 ALA A 304 1 7 HELIX 14 14 HIS A 305 ALA A 309 5 5 HELIX 15 15 LEU A 333 SER A 347 1 15 SHEET 1 A 2 PHE A 8 LEU A 13 0 SHEET 2 A 2 THR A 16 PRO A 21 -1 O THR A 16 N LEU A 13 SHEET 1 B 5 TYR A 24 PRO A 29 0 SHEET 2 B 5 VAL A 38 ASP A 43 -1 O PHE A 42 N GLN A 25 SHEET 3 B 5 ARG A 49 LYS A 54 -1 O VAL A 50 N ALA A 41 SHEET 4 B 5 TYR A 103 HIS A 107 -1 O LEU A 104 N LYS A 53 SHEET 5 B 5 ASP A 88 PHE A 90 -1 N ASP A 88 O VAL A 105 SHEET 1 C 3 ALA A 111 ASP A 112 0 SHEET 2 C 3 LEU A 156 VAL A 158 -1 O VAL A 158 N ALA A 111 SHEET 3 C 3 LEU A 164 ILE A 166 -1 O LYS A 165 N ALA A 157 SITE 1 AC1 13 VAL A 38 ALA A 51 LEU A 75 ILE A 84 SITE 2 AC1 13 LEU A 104 THR A 106 HIS A 107 LEU A 108 SITE 3 AC1 13 MET A 109 GLY A 110 ALA A 111 ALA A 157 SITE 4 AC1 13 ASP A 168 CRYST1 45.260 87.230 122.810 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022095 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011464 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008143 0.00000